(CNS) Cohen & Steers - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US19247A1007

CNS: Mutual Funds, Hedge Funds, Real Estate, Infrastructure, Commodities

Cohen & Steers, Inc. (NYSE:CNS) is a leading global investment manager specializing in real assets and alternative income strategies. Founded in 1986 and headquartered in New York, the firm provides investment solutions to institutional and individual investors worldwide. Through its subsidiaries, Cohen & Steers manages a diverse range of portfolios, including equity, fixed income, multi-asset, and commodity strategies. The firm is particularly recognized for its expertise in real estate, infrastructure, natural resources, and preferred securities, offering a unique blend of sector-specific and multi-strategy solutions. Its investment approach combines rigorous fundamental research with a disciplined, risk-aware framework to deliver long-term value for clients.

As of the latest data, Cohen & Steers has a market capitalization of $3.785 billion, with a trailing P/E of 24.27 and a forward P/E of 22.08. The firms price-to-book ratio stands at 7.40, reflecting its strong balance sheet and profitability. With a return on equity (RoE) of 29.56%, Cohen & Steers demonstrates robust operational efficiency. Technically, the stock is trading at $76.20, slightly above its 20-day SMA of $75.57 but below its 50-day and 200-day SMAs of $79.86 and $88.24, respectively. The average true range (ATR) of 3.07 indicates moderate volatility. Over the next three months, based on the current trend, the stock is likely to face resistance near its 50-day SMA and support around its 20-day SMA. Fundamentally, the firms strong profitability and focus on alternative income strategies position it well in the current market environment, though its premium valuation may limit near-term upside.

Additional Sources for CNS Stock

CNS Stock Overview

Market Cap in USD 3,917m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Asset Management & Custody Banks
IPO / Inception 2004-08-13

CNS Stock Ratings

Growth Rating 37.4
Fundamental 34.6
Dividend Rating 53.9
Rel. Strength -6.93
Analysts 3.67/5
Fair Price Momentum 69.85 USD
Fair Price DCF 31.90 USD

CNS Dividends

Dividend Yield 12m 2.94%
Yield on Cost 5y 4.94%
Annual Growth 5y 1.69%
Payout Consistency 83.9%

CNS Growth Ratios

Growth Correlation 3m -88.6%
Growth Correlation 12m 34.2%
Growth Correlation 5y 45.3%
CAGR 5y 9.76%
CAGR/Max DD 5y 0.21
Sharpe Ratio 12m 0.16
Alpha 5.06
Beta 0.615
Volatility 40.10%
Current Volume 98.2k
Average Volume 20d 220.6k
What is the price of CNS stocks?
As of April 30, 2025, the stock is trading at USD 77.13 with a total of 98,194 shares traded.
Over the past week, the price has changed by +3.78%, over one month by -3.89%, over three months by -12.17% and over the past year by +12.86%.
Is Cohen & Steers a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Cohen & Steers is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.59 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNS as of April 2025 is 69.85. This means that CNS is currently overvalued and has a potential downside of -9.44%.
Is CNS a buy, sell or hold?
Cohen & Steers has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold CNS.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CNS stock price target?
According to ValueRays Forecast Model, CNS Cohen & Steers will be worth about 77.4 in April 2026. The stock is currently trading at 77.13. This means that the stock has a potential upside of +0.34%.
Issuer Forecast Upside
Wallstreet Target Price 81 5%
Analysts Target Price 97.7 26.6%
ValueRay Target Price 77.4 0.3%